Excess risk in infant mortality among populations living in flood-prone areas in Bangladesh: A cluster-matched cohort study over three decades, 1988 to 2017
Proceedings of the National Academy of Sciences · 12.12.2023 · 120 (50)
DOI: 10.1073/pnas.2218789120 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 05.12.2023. Verfasst von Francois Rerolle und 2 weiteren Autor:innen. Beteiligte Einrichtung: Francis I. Proctor Foundation, University of California, San Francisco, CA 94518. Hauptthemen laut MEDLINE: Floods, Infant Mortality. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
The Ganges–Brahmaputra–Meghna river basin, running through Tibet, Nepal, Bhutan, Bangladesh, and northern India, is home to more than 618 million people. Annual monsoons bring extensive flooding to the basin, with floods predicted to be more frequent and extreme due to climate change. Yet, evidence regarding the long-term impacts of floods on children’s health is lacking. In this analysis, we used high-resolution maps of recent large floods in Bangladesh to identify flood-prone areas over the country. We then used propensity score techniques to identify, among 58,945 mothers interviewed in six demographic population-based surveys throughout Bangladesh, matched cohorts of exposed and unexposed mothers and leverage data on 150,081 births to estimate that living in flood-prone areas was associated with an excess risk in infant mortality of 5.3 (95% CI 2.2 to 8.4) additional deaths per 1,000 births compared to living in non-flood-prone areas over the 30-y period between 1988 and 2017, with higher risk for children born during rainy (7.9, 95% CI: 3.3 to 12.5) vs. dry months (3.1, 95% CI: –1.1 to 7.2). Finally, drawing on national-scale, high-resolution estimates of flood risk and population distribution, we estimated an excess of 152,753 (64,120 to 241,386) infant deaths were attributable to living in flood-prone areas in Bangladesh over the past 30 y, with marked heterogeneity in attributable burden by subdistrict. Our approach demonstrates the importance of measuring longer-term health impacts from floods and provides a generalizable example for how to study climate-related exposures and long-term health effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Francis I. Proctor Foundation, University of California, San Francisco, CA 94518.
- Climate, Atmospheric Science & Physical Oceanography (CASPO), Scripps Institution of Oceanography, University of California, San Diego, CA 92093.
- Department of Ophthalmology, University of California, San Francisco, CA 94518.
ORCID-Profile: Benjamin F Arnold, Tarik Benmarhnia
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
Zitieren
APA
Rerolle, F., Arnold, B. F., & Benmarhnia, T. (2023). Excess risk in infant mortality among populations living in flood-prone areas in Bangladesh: A cluster-matched cohort study over three decades, 1988 to 2017. Proceedings of the National Academy of Sciences, 120(50). https://doi.org/10.1073/pnas.2218789120
Vancouver
Rerolle F, Arnold BF, Benmarhnia T. Excess risk in infant mortality among populations living in flood-prone areas in Bangladesh: A cluster-matched cohort study over three decades, 1988 to 2017. Proceedings of the National Academy of Sciences. 2023;120(50). doi:10.1073/pnas.2218789120
BibTeX
@article{Rerolle2023,
author = {Rerolle, Francois and Arnold, Benjamin F and Benmarhnia, Tarik},
title = {Excess risk in infant mortality among populations living in flood-prone areas in Bangladesh: A cluster-matched cohort study over three decades, 1988 to 2017},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {50},
doi = {10.1073/pnas.2218789120}
}
EUVIMED